论文部分内容阅读
AIM: To evaluate the clinical outcome and cost-effectiveness of transcatheter arterial ethanol-lipiodol embolotherapy on hepatocellular carcinoma (HCC).METHODS: One hundred patients with HCC who were treated only by lobar or segmental transarterial emboli